2022 Startup Exit Awards: Wugen's $172M funding round helps develop new cancer treatments
July 28, 2022 at 14:40 PM EDT
Since raising $172 million from investors, drug development startup Wugen has made significant progress on its efforts to develop new cancer treatments, including the launch of a clinical trial.
